DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20191603

Analysis of cost between branded medicines and generic medicines in a tertiary care hospital

Mohith N., Nalini G. K., Deepak P., Sahana G. N., Jayashree V. Nagaral, Rakshitha B. V., Divyashree C. R.

Abstract


Background: There is much debate regarding the importance of promoting the use of cheaper generic alternatives over brand-name drugs. While generic drugs have been noted to be comparable to brand-name drugs in their ability to treat conditions, significant debate surrounding their bioavailability or the concentration of the drug that reaches its site of action has arisen. Many experts continue to believe that generic and brand-name drugs are bioequivalent and equally viable options for effective drug treatment, as assumed in this review.

Methods: Prices of commonly used branded and generic medicines in same concentration, dosage form and combination were compared with the help of Indian Drug Review, brochures of pharmaceuticals and pharmacies and Jan Aushadhi price list 2017. Mean of all the prices available of branded and generic medicine were calculated and the percentage difference in the mean costs of generic and branded medicines were calculated.

Results: The mean cost of 47 branded medicines out of the selected 50 medicines was higher than their generic versions. Mean cost of 3 generic medicines was higher than branded ones. Percentage difference in the mean costs of branded and generic medicines varied from <10% to >70%.

Conclusions: This study has shown a very noteworthy difference of prices between branded and generic drugs. Efforts should be taken to promote the generic medication. Misconception about low efficacy with generic drugs should be erased.


Keywords


Branded drugs, Cost-analysis, Debate, Generic drugs, Mean costs, Pharmacoeconomics

Full Text:

PDF

References


Jana S, Mondal P. Pharmacoeconomics: the need to sensitize undergraduate medical students. Ind J Pharmacol. 2005;37(5):277.

Lothium PW, Katzung BG. Basic and Clinical Pharmacology. 12th ed. New Delhi: Tata McGraw Hill; 2012: 1142.

Thakkar K, Billa G. The concept of generic drugs and patented drugs vs. brand name drugs and non-proprietary (generic) name drugs. Frontiers Pharmacol. 2013;4:113.

Generic medicines and Branded medicines. Available at: http://www.myvmc.com/treatments/generic medicines and branded medicines. Accessed 9 Aug 2017.

Generic Drugs, Available at: http://www.who.int/trade/ glossary/story034/en/WHO. Accessed 9 Aug 2017.

King DR, Kanavos P. Encouraging the use of generic medicines: implications for transition economies. Croatian Med J. 2002;43(4):462-9.

WHO. Guidance on INN, Available at: http://www.who.int/medicines/services/inn/innguidance/en/index.html. Accessed 9 August 2017.

Singhal GL, Anita K, Arun N. Jan Aushadhi stores in India and quality of medicines therein. Int J Pharm Pharm Sci. 2011;3(1):204-7.

Mukherjee R. Prescribe generic drugs: MCI to doctors, 2013. Available at: https://timesofindia.indiatimes.com/india/Prescribe-genericdrugsMCItodoctors/articleshow/18201776.cms?referral=PM. Accessed 9 August 2017.

Gautam CS, Bhanwra S. Pharmacoeconomics: Sensitization of undergraduate medical students. Ind J Pharmacol. 2005;37(5):336-.

Dadhich A, Upadhyaya M. A review: exploring branded generic drugs by Indian pharmaceutical multinational companies as a new prospect. Pharmacophore. 2011;2(6):271-5.

Product v. Process Patent under Indian Patent Law. Available at: http://www.ssrn.com/abstract=1758064 poduct v. Process Patent under Indian Patent Law. Accessed 9 Aug 2017.

Ahire K, Shukla MA, Gattani MA, Singh VI, Singh ME. A survey-based study in current scenario of generic and branded medicines. Int J Pharm Pharm Sci. 2013;5(3):705-11.

Janodia M, Pandey S, Rao JV, Sreedhar D, Ligade V, Udupa N. Patents regime in India: issues, challenges and opportunities in pharmaceutical sector. Internet J Third World Med. 2007;7:1.

Nath K. Pharma and IT to Benefit, Yojana. March, 2005:49-51.

Rohit S, Nilesh LB, Ravikiran KB, Pallavi MC, Pramod VK. The Indian pharmaceutical industry: Evolution of regulatory system and present scenario. Int Res J Pharm. 2012;5(6):49.

Janodia MD, Pandey S, Rao VJ, Sreedhar D, Ligade VS, Udupa N. Challenges and opportunities in pharmaceutical sector. Internet J Third World Med. 2008;7(1).

Aggarwal KK. Generic drugs vs patented drugs vs branded drugs vs generic names of the drugs. Available at: http:// www.blog.kkaggarwal.com/2013/02/generic-drugs-vspatented-drugs-vs-brandeddrugs-vs-generic-names-of-thedrugs. Accessed 9 August 2017.